Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish settingSanjib Saha, Fredrik Liedberg, Gottfrid Sjödahl et al.|Frontiers in Oncology|2025Cited by 0